Patents by Inventor Kristian Borg

Kristian Borg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10084301
    Abstract: A cable transit (100) is formed in one piece and comprises a frame (102) and a body formed from resilient material. The frame (102) is dimensioned to be inserted into an opening of a separating wall and has an axial extension L from a first end (104) to a second end (106). At least one through-hole (108) extends through the body in the axial extension thereof, and the cable transit is characterized in that the at least one through-hole (108) is defined by a cylindrical rim portion (110) and in that a volume (114) between the cylindrical rim portion (110) of the at least one through-hole and a frame (102) of the cable transit is recessed.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: September 25, 2018
    Assignee: Axis AB
    Inventors: Johan Persson, Emma Dreher, Kristian Borg
  • Publication number: 20170179702
    Abstract: A cable transit (100) is formed in one piece and comprises a frame (102) and a body formed from resilient material. The frame (102) is dimensioned to be inserted into an opening of a separating wall and has an axial extension L from a first end (104) to a second end (106). At least one through-hole (108) extends through the body in the axial extension thereof, and the cable transit is characterized in that the at least one through-hole (108) is defined by a cylindrical rim portion (110) and in that a volume (114) between the cylindrical rim portion (110) of the at least one through-hole and a frame (102) of the cable transit is recessed.
    Type: Application
    Filed: December 12, 2016
    Publication date: June 22, 2017
    Applicant: AXIS AB
    Inventors: Johan PERSSON, Emma DREHER, Kristian BORG
  • Patent number: 6071516
    Abstract: A method for treating a patient suffering from Post-Polio Syndrome (PPS) comprises the intravenous, intramuscular or subcutaneous administration of a pharmacologically effective amount of an immunomodulating agent, in particular gamma-globulin. Also disclosed is the use of the immunomodulating agent for the manufacture of a corresponding medicament, and a pharmaceutical composition for treatment of PPS comprising gamma-globulin.
    Type: Grant
    Filed: April 1, 1999
    Date of Patent: June 6, 2000
    Assignee: Pharmalink Baslakemedel AB
    Inventors: Henrik Gonzalez, Kristian Borg